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（平成1 年1 月 8 日受付）
哲 l，山岡
女性化乳房の原因の lっとして，抗精神病薬投与が知
られている（Ca rl so n, H.E . : N. Eng l. J. M ed., 30 : 795





女性化乳房は， 直径 2 cm 以上の硬結とした。対象は全
て男性で，服用者10 名，抗精神病薬の服用歴の無い健
常者50 名であった。全対象者から， infor m ed co nse nt を
得た。
結 果
1. 女性化乳房は，服用者群において 2 人（ 2 %）認
めたが，健常者群では認めなかった。 2. 乳汁分泌は，
服用者群及び健常者群と もに認めなかった。 3. 血清
pro lactin (PRL) 値は，女性化乳房を認めない服用者群
(n= 5 ）が健常者群（n= 35 ）より有意に高かったが，
孝 2，森本忠興3，永峰 動4
血中 lu te inz ing horm one, follicl e-stimul atin g hor m one, 
testos teron e (T ), es tr adi ol (Ez）値及び血 中T /Ez比
は，両群間で有意差を認めなかった。 4 . 女性化乳房を




PRL 血症を介した gona dot ropins の抑制（Franks, S .. et 





女性化乳房は，米国人（Nuta ll ,F.Q .: J. Cli n. Endocr ino l. 
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Gynecomastia is known to be a side effect of neuroleptics. The authors investigated 
the prevalence of gynecomastia and galactorrhea in a group of regularly neuroleptic-treated 
male patients. 
Methods: 
Gynecomastia was defined as a palpable, discrete button of firm subareolar tissue 
measuring at least 2 cm in diameter. The subjects were 100 male patients who were taking 
neuroleptic-treatment regularly. Each patient gave informed consent for the research 
involved in this study. 
Results: 
( 1) Palpable gynecomastia was present in 2% of the patient group, but not at all in the 
normal group. ( 2) Galactorrhea was not present in either patient or normal group. ( 3) 
The mean level of the serum prolactin in the group of patients without gynecomastia was 
significantly higher than that in the normal group, but there was no significant difference in 
blood luteinizing hormone, follicle-stimulating hormone, testosterone (T), estradiol (E 2) or 
T / E2 ratio between the groups. ( 4) The mean level of the T / E2 ratio in the patients 
with gynecomastia was tended to be higher than that in the group of patients without 
gynecomastia. 
Conclusions : 
Overall, theseresults seem to indicate that (i) gynecomastia is not popular in the 
Japanese population, and (ii) in male patients, neither palpable gynecomastia nor 
galactorrhea is a common side effect of neuroleptics. To clarify the relation between 
gynecomastia and neuroleptic treatment, large prospective studies are required. 
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